Abstract:Previous epidemiological studies have shown that colon cancer incidence is correlated to diet and estrogen status. Phytoestrogens are molecules with similar structures to estrogen that occur naturally in plants. There is in vitro and in vivo evidence that phytoestrogens in the diet can inhibit carcinogenesis. The phytoestrogenic mammalian lignans enterolactone (EL) and enterodiol (ED) in flaxseed have been shown to be effective in decreasing tumor incidence in carcinogenic models, but there is little data regarding their effects in non‐malignant cells. The following studies used a non‐transformed cell line of young adult mouse colonocytes (YAMC) to determine the physiological effects of ED and EL in these cells. Our results demonstrate that low levels of EL (1μM) and ED (5μM) are effective at significantly reducing cell growth 20%, similar to physiological levels of estradiol. Apoptosis was also significantly increased with this treatment. Cell cycle distribution was not changed significantly by the compounds after 96 hours of treatment, but both EL and ED significantly down regulated expression of the cell cycle regulatory gene Cyclin D1 after 24 hours. Additionally, B‐cell lymphoma 2 , a gene known to suppress apoptosis, was also down regulated at 24 hours by EL treatment. Ongoing experiments are investigating the effects of EL and ED on isogenic YAMC cell lines that either have a mutated p53 gene, over express Ras, or both. This is significant, because while they are derived from the YAMC cell line, these cells are fully transformed malignant colonocytes. Evaluating the role of ED and EL in these various cell lines will help determine at which stage of carcinogenesis these phytoestrogens may be acting and whether these effects are mediated via p53 and/or Ras pathways. Collectively, these data are the first to demonstrate that ED and EL can alter the physiology of non‐malignant colonocytes and suggest that consumption of these compounds in flaxseed may impact colon carcinogenesis. Support or Funding Information Funding is provided by ACS grant RSG‐11‐179‐01‐TBE to CDA.

Inhibitory Effects of Enterolactone on Growth and Metastasis in Human Breast Cancer

Enterolactone Inhibits Insulin-Like Growth Factor-1 Receptor Signaling In Human Prostatic Carcinoma Pc-3 Cells

Vitexins, Nature-Derived Lignan Compounds, Induce Apoptosis and Suppress Tumor Growth

Effects of Metabolites of the Lignans Enterolactone and Enterodiol on Osteoblastic Differentiation of MG-63 Cells

The CYP1A1 connection between enterolactone and breast cancer risk

Enterolactone Induces Apoptosis in Human Prostate Carcinoma Lncap Cells Via A Mitochondrial-Mediated, Caspase-Dependent Pathway

Circulating enterolactone and risk of breast cancer: a prospective study in New York

Anticancer and antimetastatic potential of enterolactone: Clinical, preclinical and mechanistic perspectives

The Chemoprotective Effects of Mammalian Lignans Enterodiol and Enterolactone in Non‐Transformed Colonocytes

Lactucin, a Bitter Sesquiterpene from Cichorium intybus, Inhibits Cancer Cell Proliferation by Downregulating the MAPK and Central Carbon Metabolism Pathway

Lycorine, an isoquinoline alkaloid, inhibits breast cancer proliferation and metastasis involving cytoskeletal protein

Effect of lily polysaccharide combined genistein on proliferation and cell cycle in human breast carcinoma cells

The Combination of Two Bioactive Constituents, Lactoferrin and Linolenic Acid, Inhibits Mouse Xenograft Esophageal Tumor Growth by Downregulating Lithocholyltaurine and Inhibiting the JAK2/STAT3-Related Pathway

Functional Polysaccharide Lentinan Suppresses Human Breast Cancer Growth Via Inducing Autophagy and Caspase-7-mediated Apoptosis

Long Non-coding RNAs Contribute to the Inhibition of Proliferation and EMT by Pterostilbene in Human Breast Cancer

The flaxseed lignan secoisolariciresinol diglucoside decreases local inflammation, suppresses NFκB signaling, and inhibits mammary tumor growth

Lycorine Inhibits Breast Cancer Growth and Metastasis Via Inducing Apoptosis and Blocking Src/FAK-involved Pathway

Anti-proliferative Effects of the Lignans to MGC-803 Gastric Cancer Cell Line and Its Correlation with Cell Cycle Related Protein

Lanostane Inhibits the Proliferation and Bone Metastasis of Human Breast Cancer Cells Via Inhibition of Rho-associated Kinase Signaling.

The Β-Glucan from Lentinus Edodes Suppresses Cell Proliferation and Promotes Apoptosis in Estrogen Receptor Positive Breast Cancers.

Oleanolic Acid Inhibits the Tumor Progression by Regulating Lactobacillus Through the Cytokine-Cytokine Receptor Interaction Pathway in 4T1-Induced Mice Breast Cancer Model